Reuben S. Harris

24.6k total citations · 7 hit papers
237 papers, 17.7k citations indexed

About

Reuben S. Harris is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Reuben S. Harris has authored 237 papers receiving a total of 17.7k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Molecular Biology, 102 papers in Virology and 67 papers in Infectious Diseases. Recurrent topics in Reuben S. Harris's work include HIV Research and Treatment (102 papers), HIV/AIDS drug development and treatment (57 papers) and Cytomegalovirus and herpesvirus research (49 papers). Reuben S. Harris is often cited by papers focused on HIV Research and Treatment (102 papers), HIV/AIDS drug development and treatment (57 papers) and Cytomegalovirus and herpesvirus research (49 papers). Reuben S. Harris collaborates with scholars based in United States, United Kingdom and Canada. Reuben S. Harris's co-authors include Michael S. Neuberger, Svend K. Petersen‐Mahrt, William L. Brown, Mark T. Liddament, Susan M. Rosenberg, Michael B. Burns, Mark D. Stenglein, Nuri A. Temiz, Eric W. Refsland and Judd F. Hultquist and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Reuben S. Harris

232 papers receiving 17.6k citations

Hit Papers

DNA Deamination Mediates Innate Immunity to Retroviral In... 2002 2026 2010 2018 2003 2002 2013 2013 2004 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. DNA Deamination Mediates Innate Immunity to Retroviral Infection
    2003 1.1k citations Reuben S. Harris et al. profile →
  2. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification
    2002 717 citations Reuben S. Harris et al. profile →
  3. APOBEC3B is an enzymatic source of mutation in breast cancer
    2013 639 citations Michael B. Burns, Michael A. Carpenter et al. profile →
  4. Evidence for APOBEC3B mutagenesis in multiple human cancers
    2013 559 citations Michael B. Burns, Nuri A. Temiz et al. profile →
  5. Retroviral restriction by APOBEC proteins
    2004 507 citations Reuben S. Harris et al. profile →
  6. APOBECs and virus restriction
    2015 385 citations Reuben S. Harris et al. profile →
  7. Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
    2023 94 citations Sofia N. Moraes, Hideki Aihara et al. Science Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reuben S. Harris United States 69 10.0k 6.9k 4.4k 4.1k 3.9k 237 17.7k
David B. Weiner United States 77 8.2k 0.8× 5.2k 0.8× 4.6k 1.1× 10.8k 2.6× 4.8k 1.2× 483 22.1k
B. Matija Peterlin United States 72 8.3k 0.8× 7.8k 1.1× 2.1k 0.5× 5.1k 1.3× 3.6k 0.9× 188 15.8k
Michael H. Malim United Kingdom 78 10.7k 1.1× 15.1k 2.2× 5.7k 1.3× 7.3k 1.8× 8.3k 2.1× 180 24.3k
Lee Ratner United States 64 4.9k 0.5× 8.6k 1.2× 2.4k 0.6× 7.1k 1.7× 5.4k 1.4× 300 17.5k
Mariano Estéban Spain 67 5.7k 0.6× 5.8k 0.8× 5.7k 1.3× 5.4k 1.3× 2.6k 0.7× 366 15.8k
Jeremy Luban United States 68 7.5k 0.8× 7.2k 1.0× 2.8k 0.6× 4.8k 1.2× 3.6k 0.9× 155 14.3k
Ronald C. Desrosiers United States 80 5.7k 0.6× 16.3k 2.4× 9.1k 2.1× 9.0k 2.2× 7.7k 2.0× 289 25.2k
Michael S. Neuberger United Kingdom 74 10.2k 1.0× 2.4k 0.3× 2.3k 0.5× 10.7k 2.6× 1.3k 0.3× 165 20.0k
Paul D. Bieniasz United States 78 7.1k 0.7× 10.6k 1.5× 6.0k 1.4× 7.1k 1.8× 6.7k 1.7× 183 21.0k
Nathaniel R. Landau United States 57 6.2k 0.6× 14.7k 2.1× 4.4k 1.0× 10.0k 2.5× 7.4k 1.9× 116 21.5k

Countries citing papers authored by Reuben S. Harris

Since Specialization
Citations

This map shows the geographic impact of Reuben S. Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reuben S. Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reuben S. Harris more than expected).

Fields of papers citing papers by Reuben S. Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reuben S. Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reuben S. Harris. The network helps show where Reuben S. Harris may publish in the future.

Co-authorship network of co-authors of Reuben S. Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Reuben S. Harris. A scholar is included among the top collaborators of Reuben S. Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reuben S. Harris. Reuben S. Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aihara, Hideki, et al.. (2025). A Novel Fluorescence Polarization Binding Assay for the Main Protease (M pro ) of SARS-CoV-2. ACS Pharmacology & Translational Science. 8(11). 4055–4069.
2.
Fanunza, Elisa, Adam Z. Cheng, Ashley A. Auerbach, et al.. (2023). Human cytomegalovirus mediates APOBEC3B relocalization early during infection through a ribonucleotide reductase-independent mechanism. Journal of Virology. 97(8). e0078123–e0078123. 6 indexed citations
3.
Durfee, Cameron, Nuri A. Temiz, Rena Levin-Klein, et al.. (2023). Human APOBEC3B promotes tumor development in vivo including signature mutations and metastases. Cell Reports Medicine. 4(10). 101211–101211. 24 indexed citations
4.
Chen, Yanjun, et al.. (2023). APOBEC Reporter Systems for Evaluating diNucleotide Editing Levels. The CRISPR Journal. 6(5). 430–446. 1 indexed citations
5.
Shi, Ke, Surajit Banerjee, Jennifer L. McCann, et al.. (2021). Structural basis for recognition of distinct deaminated DNA lesions by endonuclease Q. Proceedings of the National Academy of Sciences. 118(10). 13 indexed citations
6.
McCann, Jennifer L., Daniel J. Salamango, Emily K. Law, William L. Brown, & Reuben S. Harris. (2020). MagnEdit—interacting factors that recruit DNA-editing enzymes to single base targets. Life Science Alliance. 3(4). e201900606–e201900606. 7 indexed citations
7.
Conboy, Caitlin B., Susan K. Rathe, Juan E. Abrahante, et al.. (2020). R-Spondins 2 and 3 Are Overexpressed in a Subset of Human Colon and Breast Cancers. DNA and Cell Biology. 40(1). 70–79. 10 indexed citations
8.
Serebrenik, Artur A., Prokopios P. Argyris, Matthew C. Jarvis, et al.. (2020). The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer. Clinical Cancer Research. 26(13). 3397–3407. 48 indexed citations
9.
Evgin, Laura, Amanda L. Huff, Timothy Kottke, et al.. (2019). Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment. Cancer Immunology Research. 7(5). 828–840. 13 indexed citations
10.
Starrett, Gabriel J., Artur A. Serebrenik, Jennifer L. McCann, et al.. (2019). Polyomavirus T Antigen Induces APOBEC3B Expression Using an LXCXE-Dependent and TP53-Independent Mechanism. mBio. 10(1). 32 indexed citations
11.
Lee, Ju Youn, Michail Schizas, Felipe C. Geyer, et al.. (2018). Lobular Carcinomas In Situ Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma. Clinical Cancer Research. 25(2). 674–686. 39 indexed citations
12.
Ebrahimi, Diako, Christopher M. Richards, Michael A. Carpenter, et al.. (2018). Genetic and mechanistic basis for APOBEC3H alternative splicing, retrovirus restriction, and counteraction by HIV-1 protease. Nature Communications. 9(1). 4137–4137. 26 indexed citations
13.
Wagner, Jeffrey, Özlem Demir, Michael A. Carpenter, et al.. (2018). Determinants of Oligonucleotide Selectivity of APOBEC3B. Journal of Chemical Information and Modeling. 59(5). 2264–2273. 11 indexed citations
14.
Leonard, Brandon, Gabriel J. Starrett, Matthew J. Maurer, et al.. (2016). APOBEC3G Expression Correlates with T-Cell Infiltration and Improved Clinical Outcomes in High-grade Serous Ovarian Carcinoma. Clinical Cancer Research. 22(18). 4746–4755. 52 indexed citations
15.
Verhalen, Brandy, Gabriel J. Starrett, Reuben S. Harris, & Mengxi Jiang. (2016). Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses. Journal of Virology. 90(14). 6379–6386. 74 indexed citations
16.
Law, Emily K., Anieta M. Sieuwerts, Kelly LaPara, et al.. (2016). The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer. Science Advances. 2(10). e1601737–e1601737. 160 indexed citations
17.
Leonard, Brandon, Jennifer L. McCann, Gabriel J. Starrett, et al.. (2015). The PKC/NF-κB Signaling Pathway Induces APOBEC3B Expression in Multiple Human Cancers. Cancer Research. 75(21). 4538–4547. 106 indexed citations
18.
Bhattacharya, Chitralekha, Rui Zhu, Donna A. MacDuff, et al.. (2013). APOBEC3 inhibits DEAD-END function to regulate microRNA activity. BMC Molecular Biology. 14(1). 16–16. 14 indexed citations
19.
Hultquist, Judd F., Rebecca M. McDougle, Brett D. Anderson, & Reuben S. Harris. (2012). HIV Type 1 Viral Infectivity Factor and the RUNX Transcription Factors Interact with Core Binding Factor β on Genetically Distinct Surfaces. AIDS Research and Human Retroviruses. 28(12). 1543–1551. 28 indexed citations
20.
Albin, John S., Rebecca S. LaRue, William L. Brown, et al.. (2010). A Single Amino Acid in Human APOBEC3F Alters Susceptibility to HIV-1 Vif. Journal of Biological Chemistry. 285(52). 40785–40792. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David B. Weiner Breakdown of academic impact, for papers by B. Matija Peterlin Breakdown of academic impact, for papers by Michael H. Malim Breakdown of academic impact, for papers by Lee Ratner Breakdown of academic impact, for papers by Mariano Estéban Breakdown of academic impact, for papers by Jeremy Luban Breakdown of academic impact, for papers by Ronald C. Desrosiers Breakdown of academic impact, for papers by Michael S. Neuberger Breakdown of academic impact, for papers by Paul D. Bieniasz Breakdown of academic impact, for papers by Nathaniel R. Landau
Rankless by CCL
2026